NMR structure note: PHD domain from death inducer obliterator protein and its interaction with H3K4me3.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Contributions of methionine to recognition of trimethyllysine in aromatic cage of PHD domains: implications of polarizability, hydrophobicity, and charge on binding.Chemical science · 2021
   Article
2. Role of DIDO1 in Progression of Esophageal Squamous Cell Carcinoma.Journal of gastrointestinal cancer · 2020
   Article
3. ROW1 maintains quiescent centre identity by confining WOX5 expression to specific cells.Nature communications · 2015
   Article
4. Dido3-dependent HDAC6 targeting controls cilium size.Nature communications · 2014
   Article
5. The death-inducer obliterator 1 (Dido1) gene regulates embryonic stem cell self-renewal.The Journal of biological chemistry · 2014
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as